Antiretroviral therapy switch among Medicare beneficiaries with HIV

20260 citationsJournal Article

Authors

Mary J. Christoph · Gilead Sciences (United States)

Uche Mordi · Gilead Sciences (United States)

S. Li · Metro-Minnesota Community Oncology Research Consortium

Haifeng Guo · Metro-Minnesota Community Oncology Research Consortium

TingTing Gong · Metro-Minnesota Community Oncology Research Consortium

Travis Lim · Gilead Sciences (United States)

Seojin Park

Abstract

Medicare-insured PWH indexed on B/F/TAF had lower risk of treatment switch compared with other ART regimens, both overall and in the subgroup with mental health and/or substance use disorders. These findings may inform targeted strategies for optimal treatment selection for PWH.

Topics & Keywords

HIV/AIDS Research and Interventions HIV-related health complications and treatments HIV/AIDS drug development and treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Managed Care & Specialty Pharmacy

DOI: 10.18553/jmcp.2026.25275

Field-Weighted Citation Impact: 0.00